Therefore, while adult and pediatric brain cancers do differ, the common players that cross-talk with HGF/MET are potential avenues for further investigation in order to delineate the cooperative or synergistic interactions between the said molecules in pediatric brain cancers and develop new treatment approaches. This evidence concerns the gene HGF and brain cancer.